Walter E. Aulitzky
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 31
- Acute Myeloid Leukemia Research 22
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 25
- Oncology top 2%
- Cancer-related Molecular Pathways 11
- Cancer Research top 5%
- Immunology top 5%
- Immune Cell Function and Interaction 10
-
- Lymphoma Diagnosis and Treatment 11
-
- Acute Lymphoblastic Leukemia research 11
-
- Eosinophilic Disorders and Syndromes 10
- Co-authors
- Heiko van der KuipJustus DuysterSimon HeineMoshe OrenKathrin BöppleMarkus KleihChristian PeschelFrank Eßmann
- Cited by
- HematologyGeneticsOncology
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Walter E. Aulitzky
119 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 124
- Hematology 1.1k
- Genetics 692
- Oncology 1.1k
- Cancer Research 385
- Immunology 502
Countries citing papers authored by Walter E. Aulitzky
This map shows the geographic impact of Walter E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. Aulitzky more than expected).
Fields of papers citing papers by Walter E. Aulitzky
This network shows the impact of papers produced by Walter E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. Aulitzky. The network helps show where Walter E. Aulitzky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Walter E. Aulitzky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 7 | |
| 3 | 2022 | 5 | |
| 4 | 2017 | 1 | |
| 5 | 2016 | 60 | |
| 6 | 2015 | 7 | |
| 7 | 2013 | 47 | |
| 8 | 2012 | 24 | |
| 9 | 2009 | 19 | |
| 10 | 2008 | 74 | |
| 11 | 2006 | 85 | |
| 12 | 1996 | 17 | |
| 13 | 1996 | 11 | |
| 14 | 1995 | 2 | |
| 15 | 1993 | 15 | |
| 16 | 1990 | 6 | |
| 17 | 1990 | 16 | |
| 18 | 1989 | 17 | |
| 19 | 1988 | 12 | |
| 20 | 1985 | 10 |
About Walter E. Aulitzky
Walter E. Aulitzky is a scholar working on Hematology, Genetics and Oncology, having authored 121 papers that have together received 3.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (31 papers), Chronic Lymphocytic Leukemia Research (25 papers), Acute Myeloid Leukemia Research (22 papers), Cancer-related Molecular Pathways (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Lymphoblastic Leukemia research (11 papers), Eosinophilic Disorders and Syndromes (10 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (692 citations) and Oncology (1.1k citations). Walter E. Aulitzky has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Heiko van der Kuip, Justus Duyster, Simon Heine, Moshe Oren, Kathrin Böpple, Markus Kleih, Christian Peschel, Frank Eßmann, Cornelius Miething and Meng Dong. Their work appears in journals such as Blood, Annals of Hematology, Cancer Research, Cell Death and Disease and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.